Captrust Financial Advisors Geron Corp Transaction History

Captrust Financial Advisors

$30.9 Billion
Q2 2024

A detailed history of Captrust Financial Advisors transactions in Geron Corp stock. As of the latest transaction made, Captrust Financial Advisors holds 11,944 shares of GERN stock, worth $56,614. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,944

Previous 10,164 17.51%

Holding current value

$56,614

Previous $33,000 51.52%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.1 - $5.09 $5,518 - $9,060	1,780 Added 17.51%	11,944 $50,000
Q1 2024 May 15, 2024	SELL	$1.75 - $3.44 $12,834 - $25,228	-7,334 Reduced 41.91%	10,164 $33,000
Q4 2023 Feb 14, 2024	SELL	$1.74 - $2.31 $5,628 - $7,472	-3,235 Reduced 15.6%	17,498 $36,000
Q3 2023 Nov 14, 2023	SELL	$2.11 - $3.28 $16,114 - $25,049	-7,637 Reduced 26.92%	20,733 $43,000
Q2 2023 Aug 14, 2023	BUY	$1.97 - $3.69 $14,416 - $27,003	7,318 Added 34.76%	28,370 $91,000
Q1 2023 May 15, 2023	BUY	$2.14 - $3.4 $45,051 - $71,576	21,052 New	21,052 $45,000
Q2 2022 Aug 16, 2022	BUY	$1.19 - $1.65 $2,533 - $3,512	2,129 Added 81.88%	4,729 $7,000
Q1 2022 May 16, 2022	SELL	$0.99 - $1.6 $22 - $36	-23 Reduced 0.88%	2,600 $4,000
Q3 2021 Nov 16, 2021	SELL	$1.2 - $1.5 $3,636 - $4,545	-3,030 Reduced 53.6%	2,623 $4,000
Q2 2021 Aug 16, 2021	SELL	$1.25 - $1.83 $14,212 - $20,807	-11,370 Reduced 66.79%	5,653 $8,000
Q1 2021 May 17, 2021	BUY	$1.52 - $2.1 $22,800 - $31,500	15,000 Added 741.47%	17,023 $27,000
Q4 2020 Feb 16, 2021	BUY	$1.55 - $2.05 $35 - $47	23 Added 1.15%	2,023 $3,000
Q3 2020 Nov 17, 2020	SELL	$1.59 - $2.19 $36 - $50	-23 Reduced 1.14%	2,000 $4,000
Q2 2020 Aug 14, 2020	BUY	$1.05 - $2.18 $2,124 - $4,410	2,023 New	2,023 $4,000
Q4 2019 Feb 14, 2020	SELL	$1.27 - $1.54 $29 - $35	-23 Closed	0 $0
Q3 2018 Nov 15, 2018	SELL	$1.76 - $6.38 $10,519 - $38,133	-5,977 Reduced 99.62%	23 $0
Q2 2018 Aug 13, 2018	BUY	$3.29 - $4.82 $3,290 - $4,820	1,000 Added 20.0%	6,000 $21,000
Q1 2018 May 15, 2018	BUY	$1.81 - $5.98 $9,050 - $29,900	5,000 New	5,000 $20,000

Others Institutions Holding GERN

# of Institutions

257

Shares Held

448M

Call Options Held

1.91M

Put Options Held

897K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.79B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Geron Corp Transaction History